Spots Global Cancer Trial Database for neoplasm, breast
Every month we try and update this database with for neoplasm, breast cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment. | NCT05507034 | Neoplasm, Breas... Carcinoma Breas... Chronic Pain | Biomarkers | 25 Years - 65 Years | Universiteit Antwerpen | |
| Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy | NCT04109079 | Breast Cancer Sentinel Lymph ... Neoplasm, Breas... | Axillary lymph ... Axillary radiot... Breast or chest... | 18 Years - | University Hospitals of Derby and Burton NHS Foundation Trust | |
| Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer | NCT05033769 | Breast Cancer F... Neoplasm, Breas... Breast Cancer M... | Eribulin Inject... Paclitaxel inje... | 18 Years - | Institut fuer Frauengesundheit | |
| DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein | NCT03368196 | Adenocarcinoma,... Neoplasm, Breas... | DS-8201a | 20 Years - | Daiichi Sankyo | |
| SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast) | NCT05392608 | Neoplasm, Breas... Congenital, Fam... | Alpelisib 150 M... Fulvestrant | 18 Years - | Borstkanker Onderzoek Groep | |
| Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer | NCT05033769 | Breast Cancer F... Neoplasm, Breas... Breast Cancer M... | Eribulin Inject... Paclitaxel inje... | 18 Years - | Institut fuer Frauengesundheit | |
| To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes | NCT03715686 | Neoplasm, Breas... Neoadjuvant Che... Lymph Node Meta... Response | wire localizati... | 18 Years - 65 Years | Peking University | |
| Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients | NCT04678544 | Neoplasm, Breas... | Scalp cooling s... | 20 Years - 69 Years | Samsung Medical Center | |
| 9-ING-41 in Patients With Advanced Cancers | NCT03678883 | Cancer Pancreatic Canc... Sarcoma Renal Cancer Refractory Canc... Refractory Neop... Refractory Non-... Pancreatic Aden... Resistant Cance... Neoplasm Metast... Neoplasm of Bon... Neoplasm, Breas... Neoplasm of Lun... Neoplasms,Color... Neoplasms Pancr... Malignant Gliom... Malignancies Malignancies Mu... Bone Metastases Bone Neoplasm Bone Cancer Pancreas Cancer Pancreatic Neop... Breast Neoplasm... Acute T Cell Le... | 9-ING-41 Gemcitabine - 2... Doxorubicin. Lomustine Carboplatin. Nab paclitaxel. Paclitaxel. Gemcitabine - 2... Irinotecan | 18 Years - | Actuate Therapeutics Inc. | |
| Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer | NCT05033769 | Breast Cancer F... Neoplasm, Breas... Breast Cancer M... | Eribulin Inject... Paclitaxel inje... | 18 Years - | Institut fuer Frauengesundheit | |
| DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein | NCT03368196 | Adenocarcinoma,... Neoplasm, Breas... | DS-8201a | 20 Years - | Daiichi Sankyo | |
| Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study | NCT05851053 | Neoplasm, Breas... Heart Failure Cardiotoxicity Ventricular Dys... | Echocardiograph... | - | University Medical Center Groningen | |
| TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer | NCT06251544 | Breast Cancer Tumor, Breast Breast Tumor Malignant Neopl... Mammary Cancer Mammary Neoplas... Mammary Neoplas... Neoplasm, Breas... | HTR2 T Cells HTR2 T Cells | 18 Years - 80 Years | Baylor College of Medicine | |
| To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes | NCT03715686 | Neoplasm, Breas... Neoadjuvant Che... Lymph Node Meta... Response | wire localizati... | 18 Years - 65 Years | Peking University | |
| TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer | NCT06251544 | Breast Cancer Tumor, Breast Breast Tumor Malignant Neopl... Mammary Cancer Mammary Neoplas... Mammary Neoplas... Neoplasm, Breas... | HTR2 T Cells HTR2 T Cells | 18 Years - 80 Years | Baylor College of Medicine | |
| Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients | NCT04678544 | Neoplasm, Breas... | Scalp cooling s... | 20 Years - 69 Years | Samsung Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
